Faculty Opinions recommendation of Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study.

Author(s):  
Jack Kron
2018 ◽  
Vol 4 (6) ◽  
pp. 241-246 ◽  
Author(s):  
Madhukar Kollengode ◽  
Jehu Mathew ◽  
Elizabeth Yeung ◽  
William H. Sauer ◽  
Duy Thai Nguyen

2019 ◽  
Vol 42 (7) ◽  
pp. 910-921 ◽  
Author(s):  
Ugur Canpolat ◽  
Duygu Kocyigit ◽  
Muhammed Ulvi Yalcin ◽  
Cem Coteli ◽  
Yusuf Ziya Sener ◽  
...  

Heart Rhythm ◽  
2014 ◽  
Vol 11 (11) ◽  
pp. 1904-1911 ◽  
Author(s):  
Fabien Squara ◽  
David S. Frankel ◽  
Robert Schaller ◽  
Suraj Kapa ◽  
William W. Chik ◽  
...  

2007 ◽  
Vol 17 (2) ◽  
pp. 103-109 ◽  
Author(s):  
Imran Sheikh ◽  
David Krum ◽  
Ryan Cooley ◽  
Anwer Dhala ◽  
Zalmen Blanck ◽  
...  

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii181-iii181
Author(s):  
M. Riemann ◽  
NCF Sandgaard ◽  
J. Dalhoj ◽  
S. Djurhuus ◽  
JB. Johansen ◽  
...  

2021 ◽  
pp. 52-55
Author(s):  
Adi Lador ◽  
Miguel Valderrábano

Catheter ablation has become a cornerstone treatment for atrial fibrillation (AF). Pulmonary vein isolation is the accepted approach for paroxysmal AF ablation, but it is less effective for persistent AF. The vein of Marshall (VOM) is located in the epicardial left atrium and can be a source of AF triggers as well as a tract for autonomic nerves. It directly communicates with the underlying myocardium, including the left atrial ridge and the posterior mitral isthmus. This review discusses the latest evidence regarding the mechanisms, procedural aspects, and outcomes of VOM ethanol infusion when used as an adjunct to pulmonary vein isolation in patients with persistent AF.


Sign in / Sign up

Export Citation Format

Share Document